Heart Failure Reviews

Papers
(The H4-Index of Heart Failure Reviews is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making49
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction38
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis37
The cardiosplenic axis: the prognostic role of the spleen in heart failure34
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction28
The role of TAVR in patients with heart failure: do we have the responses to all questions?27
Correction to: Is it time to revisit ICD indications?26
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?24
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition24
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?21
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers20
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging19
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond19
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease19
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure17
Targeting mitochondrial dysfunction with elamipretide16
0.17616391181946